Drugs & Clinical Trials
Alzheimer’s Drug to Treat Binge Eating Disorder
Memantine (Namenda) is approved to treat Alzheimer’s disease, but may also be effective in treating binge eating disorder. A new study published in the International Journal of Eating Disorders demonstrates memantine’s effectiveness in a small group of patients with binge eating disorder.
Binge eating is a relatively newly recognized psychiatric disorder that involves recurrent episodes of binge eating without extreme behaviors to lose weight. Binge eating is the most common eating disorder, affecting up to 3% of American adults. It is most often seen in people aged 46 to 55 years. Binge eating is typically characterized by eating unusually large amounts of food, and most people with this disorder feel their eating is out of control. They may also eat more quickly than normal during binge episodes, eat until they are uncomfortably full, eat large amounts of food when they not hungry, eat alone to avoid embarrassment, and feel guilty, disgusted, or depressed after eating.
The current study involved 16 participants with binge eating disorder, 15 of whom completed at least one follow-up session, and 9 of whom completed the entire study. This was an open-label, 12-week trial to assess the efficacy of memantine in binge eating disorder. The individuals received a flexible dose of memantine, ranging from 5 to 20 mg daily. (The normal daily dose of memantine in the treatment of Alzheimer’s disease is 20 mg daily.) The primary outcome was frequency of binge eating days. Secondarily, the researchers evaluated the frequency of binge episodes, body mass index (BMI), weight, Clinical Global Impressions Severity (CGI-S), Three Factor Eating Questionnaire (TFEQ), Montgomery-Asberg Depression Rating Scale (MADRS), Hamilton Anxiety Rating Scale (HAM-A), and Sheehan Disability Scale (SDS).
Memantine significantly reduced the frequency of binge days and binge episodes, as well as severity of illness, disinhibition as measured by the TEFQ, and disability measured on the SDS. The number of binge days per week decreased from 4.4 to 1.1, and the number of binge episodes per week decreased from 5.5 to 1.2. There was no significant change in BMI, body weight, depression, or anxiety. Memantine was well tolerated by the participants.
The small patient population, short study duration, and lack of a placebo-controlled group limit the application of the results. Still, the results are the latest in a series of similar promising results in both animal and human models.
Recent data has pointed to a dysfunction in the activity of the neurotransmitter glutamate in mood disorders, anxiety disorders, obsessive-compulsive disorders, and schizophrenia. Memantine acts as an antagonist at the N-methyl-d-aspartate glutamate receptor, and has been used off-label for various psychiatric disorders, with encouraging results. However, without large, controlled, clinical trials, the routine use of memantine for such disorders is not recommended. The researchers that conducted the current study are planning large, placebo-controlled studies to assess the effectiveness of memantine in eating disorders.
References
A BISAGA, W DANYSZ, R FOLTIN (2008). Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder European Neuropsychopharmacology, 18 (11), 794-802 DOI: 10.1016/j.euroneuro.2008.05.004
Brian P. Brennan, Jacqueline L. Roberts, Kate V. Fogarty, Karina A. Reynolds, Jeffrey M. Jonas, James I. Hudson (2008). Memantine in the treatment of binge eating disorder: An open-label, prospective trial International Journal of Eating Disorders, 41 (6), 520-526 DOI: 10.1002/eat.20541
Zdanys K, Tampi RR (2008). A systematic review of off-label uses of memantine for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry, 32 (6), 1362-1374 PMID: 18262702
4 Comments/Trackbacks
Interesting study, though definitely needs to be on a larger scale. My feeling why memantine works is due to where the drug targets in the brain. Though the Alzheimer’s and BED are entirely different, it looks like memantine can help by blocking the NMDA glutamate receptors. With BED, this might be helpful in controlling the hormone leptin signaling.
“There was no significant change in BMI, body weight, depression, or anxiety. ”
Doesn’t seem like it was subjectively helpful to the patients, then.
I’m leery of any drug that promises to fix an illness that has been around for centuries. It seems to me that these drugs never pan out. What has finally worked for me is joining a 12 step program to fight my disease from the emotional/spiritual angle.
Leave a Reply
Tuesday, March 16, 2010
- Religion - A "Natural" Phenomenon?
- Psychotropics and Youth, Part 1 - The Five Myths
- How Culture Shapes Our Mind and Brain
- Sex, Violence and The Male Warrior Hypothesis
- The Secret to Good Health – Listen to the Data
- If Herbal Medicine is Medicine, Shouldn't it be Treated as Such?
- Neurology, Neurosurgery, and Neuroscience Conferences for 2010
- Too Much Information?
- "I Feel Your Pain" - The Neural Basis of Empathy
- Income Inequality and Health Outcomes
- The Evolution of Depression
- Journal Retracts Autism Research
- Speaking in Tongues - A Neural Snapshot
- The Neural Basis of the Self
- Post-Partum Psychosis - Rare but Real
- Is Your Doctor Happy or Burnt-Out?
- Ginkgo Biloba Ineffective... Again
- Worried Well on the Web
- Psychotropics and Youth, Part 2 - The Solutions
- Why Some Human Brains Become Leaders, While Others Followers?
- My Nephew and his Brain, Part 1 – Introduction
- Deep Brain Stimulation – A New Frontier in Psychiatry
- Psychotropics and Youth, Part 3 – Equip Teachers with Prescription Pads?
- Why Some Human Brains Become Leaders, While Others Followers?
- Brain Blogger Finalist for Two 2010 Research Blogging Awards in Neuroscience and Psychology
- Tall Tales of Diabetic Amputations
- Psychotropics and Youth, Part 2 – The Solutions
- Brain Blogging, Forty-Ninth Edition
- How Your Brain Groups Words
- The Child Brain and the Playing Teacher
- You Have a Right to Choose if we Agree
- Measuring Quality in Primary Care
- Matchmaker, Matchmaker Make Me A Match – The NRMP Main Residency Match
- Psychotropics and Youth, Part 1 – The Five Myths
- When It Comes to Aging, Size Matters
- “I Feel Your Pain” – The Neural Basis of Empathy
- Speaking in Tongues – A Neural Snapshot
- Neuro Case 1 – Using Transcranial Doppler for Basilar Artery Occlusion
- Journal Retracts Autism Research
- Crossing the Line from Physician to Journalist
- It's been almost 25 years since my son suffered a TBI in an accident. He was onl...
- I tend to agree with the teachers.But a teacher can only keep a record about the...
- Very interesting article, the 5th paragraph gets a little biased...but I still e...
- Dear Dan,There is certainly much clinical interest in this field. ClinicalTr...
- I recently commented on a sciencedaily.com article reporting success with TRD an...
- I have family members who are teachers. After sharing this article with them, th...
- It is great that people are challenging the use of this medication. As, a societ...
- I agree with the stand of the teachers and their children's that more than half ...
- I think that there’s also a social aspect to it. If you grow up in an area where...
- I have had epilepsy since I was 9 and am now 42. I have tried about every med. o...
- In this text is a serious error. Brain areas are found that contain religious ex...
- It's amazing how the brain works....
- Organ transplant for unavoidable patients have been around for quite some time a...
- Diet plays a major role in having diabetes. In today's world, people are finding...
- Interesting... I think that there's also a social aspect to it. If you grow up i...
- I think the article is actually describing a normal human being. Leadership tra...
- I think that applies to leaders within certain fields of knowledge or creativity...
- Thank you for your comments, Shaheen. Your article was quite interesting and you...
- Dear Bill,I wrote on this issue for ...
- In December we had the findings that suggested we not have mammograms if we are ...
Sponsored Links
Diet and Health Supplements, Best vitamins supplements, Brain Fitness DVD, Home Care, Alcohol Rehab, Emergency Lighting, Online Criminal Justice Degrees, Tattoo, Health Insurance, Cheap Mobile Phone , Rollup Banner Stands , Biotechnology , Metastatic Breast Cancer , Buy Deplin , Cystic Fibrosis Symptoms , Erlotinib , Dallas health insurance , Hand and Finger , Short Term Disability Insurance , Lung Cancer Treatment , Plano auto accident attorney , What Causes Abdominal Obesity? , Edgepark Medical , Mattress , Hydroxycut, Astrology compatibility.
Neuroscience & Neurology
March 06, 2010 | 6 Comments | By Simi Agarwal, DDS
Why Some Human Brains Become Leaders, While Others Followers?
More In Neuroscience & Neurology
- How Your Brain Groups Words
- The Child Brain and the Playing Teacher
- “I Feel Your Pain” – The Neural Basis of Empathy
- Speaking in Tongues – A Neural Snapshot
- Neuro Case 1 – Using Transcranial Doppler for Basilar Artery Occlusion
Neuroscience & Neurology
Opinion
February 01, 2010 | 1 Comment | By Jennifer Gibson, PharmD
Crossing the Line from Physician to Journalist
More In Opinion
- Sex, Violence and The Male Warrior Hypothesis
- Bruxism and the Brain
- Religion – A “Natural” Phenomenon?
- Natural Good, Chemical Bad – Right?
- Time for a Change – Gender Reassignment
Opinion
Psychiatry & Psychology
March 12, 2010 | 3 Comments | By Shaheen E Lakhan, MS, MEd, PhD, MD
Deep Brain Stimulation – A New Frontier in Psychiatry
More In Psychiatry & Psychology
- Psychotropics and Youth, Part 2 – The Solutions
- Psychotropics and Youth, Part 1 – The Five Myths
- Journal Retracts Autism Research
- White Bears – The Paradox of Mental Suppression
- Sugar and Spice and Everything Nice?


Hmm – that’s interesting. I wonder how it works (if it does?) I’d have thought that any appetite suppressant would be effective in B.E.D – does memantine suppress appetite? It’s a D2 agonist, amongst other things, so it might do.
Also, I know that antidepressants reduce binge eating in bulemia, and memantine has been trialled as an antidepressant (although it doesn’t seem to work very well.)